Exchange Traded Concepts, LLC Invitae Corp Transaction History

Exchange Traded Concepts, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 18, 2021	SELL	$24.31 - $33.6 $2.18 Million - $3.01 Million	-89,628 Closed	0 $0
Q2 2021 Jul 30, 2021	BUY	$26.09 - $40.4 $2.34 Million - $3.62 Million	89,628 New	89,628 $3.02 Million
Q1 2021 Apr 20, 2021	SELL	$33.06 - $56.93 $85,592 - $147,391	-2,589 Closed	0 $0
Q4 2020 Jan 19, 2021	SELL	$39.09 - $57.4 $522,906 - $767,839	-13,377 Reduced 83.78%	2,589 $108,000
Q3 2020 Oct 30, 2020	SELL	$28.43 - $44.67 $15,124 - $23,764	-532 Reduced 3.22%	15,966 $692,000
Q2 2020 Jul 15, 2020	BUY	$11.71 - $30.29 $116,420 - $301,143	9,942 Added 151.65%	16,498 $500,000
Q1 2020 Apr 14, 2020	BUY	$7.64 - $27.5 $18,832 - $67,787	2,465 Added 60.25%	6,556 $90,000
Q4 2019 Jan 22, 2020	BUY	$15.02 - $20.57 $61,446 - $84,151	4,091 New	4,091 $66,000

2.12M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

Stay updated on Exchange Traded Concepts, LLC with notifications on news.